Method for diagnosing type II diabetes or monitoring therapeutic effects of therapeutic agents for type II diabetes
US7435551B2 · kind B2 · utility
1Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2005 |
| Grant date | Oct 14, 2008 |
| Priority date | — |
| Expiry date | Feb 13, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/042
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method for diagnosing geriatric diseases associated with insulin resistance, such as type II diabetes, at an early stage and a method for monitoring the therapeutic effects of agents for type II diabetes by quantitatively assaying GBP28 with the use of a monoclonal antibody that can assay adiponectin (GBP28) in a sample.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.